Anti-HYAL4 monoclonal antibody

Pre-made anti-HYAL4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to HYAL4/HYAL4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0993-Ab-1/ GM-Tg-hg-IP0993-Ab-2Anti-Human HYAL4 monoclonal antibodyHuman
GM-Tg-rg-IP0993-Ab-1/ GM-Tg-rg-IP0993-Ab-2Anti-Rat HYAL4 monoclonal antibodyRat
GM-Tg-mg-IP0993-Ab-1/ GM-Tg-mg-IP0993-Ab-2Anti-Mouse HYAL4 monoclonal antibodyMouse
GM-Tg-cynog-IP0993-Ab-1/ GM-Tg-cynog-IP0993-Ab-2Anti-Cynomolgus/ Rhesus macaque HYAL4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0993-Ab-1/ GM-Tg-felg-IP0993-Ab-2Anti-Feline HYAL4 monoclonal antibodyFeline
GM-Tg-cang-IP0993-Ab-1/ GM-Tg-cang-IP0993-Ab-2Anti-Canine HYAL4 monoclonal antibodyCanine
GM-Tg-bovg-IP0993-Ab-1/ GM-Tg-bovg-IP0993-Ab-2Anti-Bovine HYAL4 monoclonal antibodyBovine
GM-Tg-equg-IP0993-Ab-1/ GM-Tg-equg-IP0993-Ab-2Anti-Equine HYAL4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0993-Ab-1/ GM-Tg-hg-IP0993-Ab-2; GM-Tg-rg-IP0993-Ab-1/ GM-Tg-rg-IP0993-Ab-2;
GM-Tg-mg-IP0993-Ab-1/ GM-Tg-mg-IP0993-Ab-2; GM-Tg-cynog-IP0993-Ab-1/ GM-Tg-cynog-IP0993-Ab-2;
GM-Tg-felg-IP0993-Ab-1/ GM-Tg-felg-IP0993-Ab-2; GM-Tg-cang-IP0993-Ab-1/ GM-Tg-cang-IP0993-Ab-2;
GM-Tg-bovg-IP0993-Ab-1/ GM-Tg-bovg-IP0993-Ab-2; GM-Tg-equg-IP0993-Ab-1/ GM-Tg-equg-IP0993-Ab-2
Products NameAnti-HYAL4 monoclonal antibody
Formatmab
Target NameHYAL4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-HYAL4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0993-Ag-1Recombinant multi-species HYAL4/ CSHY protein


    Target information

    Target IDGM-IP0993
    Target NameHYAL4
    Gene ID23553,77042,404783,696805,518161,100056514
    Gene Symbol and Synonyms4632428M18Rik,CSHY,HYAL-4,HYAL4
    Uniprot AccessionQ2M3T9
    Uniprot Entry NameHYAL4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000106302
    Target ClassificationN/A

    The target: HYAL4, gene name: HYAL4, also named as CSHY. This gene encodes a protein which is similar in structure to hyaluronidases but lacks hyaluronidase activity. The encoded protein acts as a chondroitin-sulfate-specific endo-beta-N-acetylgalactosaminidase; that is, it exhibits hydrolytic activity toward chondroitin sulfate chains and degrades them into oligosaccharides. Proteoglycans are formed by the covalent linkage of chondroitin sulfate chains to protein. Proteoglycans are ubiquitous components of the extracellular matrix of connective tissues and are also found at the surface of many cell types where they participate in a variety of cellular processes such as cell proliferation, differentiation, migration, cell-cell recognition, extracellular matrix deposition, and tissue morphogenesis. The expression of this gene is highest in testes and placenta. [provided by RefSeq, Apr 2019].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.